EDSA 424B3: Secondary offering
Edesa Biotech
Filed with the SEC on · accession 0001171843-26-004604
EDSA filed a 424B3 (prospectus (offering)) with the SEC on Jul 13, 2026. Edesa Biotech filed a prospectus for the resale of up to 729,241 common shares by selling shareholders from a private placement on June 10, 2026. The stock moved -2.9% by the first close after the filing.
Summary of the filing
Edesa Biotech filed a prospectus for the resale of up to 729,241 common shares by selling shareholders from a private placement on June 10, 2026. The company will not receive any proceeds from the resale.
Key details
How EDSA stock reacted
Close before
$7.01
Jul 10, 2026
First close after
-2.85%
$6.81
5 trading days
-5.85%
$6.60
Since filing
-69.47%
$2.14
✦ Ask GOAX AI about this filing — what it means for EDSA, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for EDSA?
Click hereFrequently asked questions
What did EDSA file with the SEC on Jul 13, 2026?
EDSA filed a 424B3 (Secondary offering). Edesa Biotech filed a prospectus for the resale of up to 729,241 common shares by selling shareholders from a private placement on June 10, 2026. The company will not receive any proceeds from the resale.
What does a secondary offering mean for EDSA stock?
New shares dilute existing holders and are often sold at a discount to the market price.
How do I read a 424B3?
The final terms of an offering of shares or bonds. Look at price, number of shares and the discount to the market price. Large offerings dilute existing shareholders.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 424B3 (prospectus (offering)): The final terms of an offering of shares or bonds.
How did EDSA stock react to this filing?
EDSA closed at $7.01 before the filing and $6.81 on Jul 13, 2026 (-2.85%). Five trading days later: $6.60 (-5.85%).
Other EDSA SEC filings
- SCHEDULE 13G/A · SEC filingNov 4, 2026
- 8-K · SEC filingOct 23, 2026
- 8-K · Fda approvalOct 15, 2026
- SCHEDULE 13G · SEC filingAug 26, 2026
- SCHEDULE 13D/A · SEC filingAug 25, 2026
- SCHEDULE 13D/A · SEC filingAug 25, 2026
- 8-K · Secondary offeringAug 20, 2026
- 424B5 · Secondary offeringAug 20, 2026
- 424B5 · Secondary offeringAug 19, 2026
- 10-Q · SEC filingAug 13, 2026
Get alerts when EDSA files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days